These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 14695629

  • 21. Expression of BAX in plasma cell dyscrasias.
    Renner S, Weisz J, Krajewski S, Krajewska M, Reed JC, Lichtenstein A.
    Clin Cancer Res; 2000 Jun; 6(6):2371-80. PubMed ID: 10873089
    [Abstract] [Full Text] [Related]

  • 22. Chronic lymphocytic leukemia in the elderly population.
    Rai KR.
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [Abstract] [Full Text] [Related]

  • 23. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D.
    In Vivo; 2007 May; 21(1):123-32. PubMed ID: 17354625
    [Abstract] [Full Text] [Related]

  • 24. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
    Pangalis GA, Siakantaris MP, Angelopoulou MK, Vassilakopoulos TP, Dimopoulou MN, Kyrtsonis MC, Konstantopoulos K, Tsaftaridis P, Vaiopoulos GA, Kontopidou FN.
    Haematologica; 2002 May; 87(5):500-6. PubMed ID: 12010663
    [Abstract] [Full Text] [Related]

  • 25. Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
    Bogner C, Sandherr M, Perker M, Weick K, Ringshausen I, Peschel C, Decker T.
    Ann Hematol; 2006 Jul; 85(7):458-62. PubMed ID: 16538501
    [Abstract] [Full Text] [Related]

  • 26. Mcl-1 correlates with reduced apoptosis in neutrophils from patients with sepsis.
    Härter L, Mica L, Stocker R, Trentz O, Keel M.
    J Am Coll Surg; 2003 Dec; 197(6):964-73. PubMed ID: 14644285
    [Abstract] [Full Text] [Related]

  • 27. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C, Cosialls AM, Barragán M, Iglesias-Serret D, Santidrián AF, Coll-Mulet L, de Frias M, Domingo A, Pons G, Gil J.
    Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
    [Abstract] [Full Text] [Related]

  • 28. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A.
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [Abstract] [Full Text] [Related]

  • 29. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
    Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC.
    J Clin Oncol; 2007 Mar 01; 25(7):799-804. PubMed ID: 17283363
    [Abstract] [Full Text] [Related]

  • 30. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
    Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A.
    Clin Cancer Res; 2007 Apr 01; 13(7):2226-35. PubMed ID: 17404107
    [Abstract] [Full Text] [Related]

  • 31. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
    Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM, de Boer JP, de Jong D, Green SR, van Oers MH, Eldering E.
    Cell Death Differ; 2007 Nov 01; 14(11):1958-67. PubMed ID: 17703234
    [Abstract] [Full Text] [Related]

  • 32. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C, Paniagua M, Tallman M, Gartenhaus RB.
    Cytometry B Clin Cytom; 2005 Jan 01; 63(1):36-46. PubMed ID: 15624202
    [Abstract] [Full Text] [Related]

  • 33. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA, Boyiadzis M, Land SR, Marks S, Raptis A, Pietragallo L, Meisner D, Laman A, Sulecki M, Butchko A, Schaefer P, Lenzer D, Tarhini A.
    J Clin Oncol; 2009 Feb 01; 27(4):498-503. PubMed ID: 19075274
    [Abstract] [Full Text] [Related]

  • 34. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
    Roué G, López-Guerra M, Milpied P, Pérez-Galán P, Villamor N, Montserrat E, Campo E, Colomer D.
    Clin Cancer Res; 2008 Nov 01; 14(21):6907-15. PubMed ID: 18980985
    [Abstract] [Full Text] [Related]

  • 35. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR, Goodrich A, Park K, Waselenko JK, Lucas M, Reese A, Diehl LF, Grever MR, Byrd JC, Flinn IW.
    Ann Hematol; 2006 May 01; 85(5):301-7. PubMed ID: 16518606
    [Abstract] [Full Text] [Related]

  • 36. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
    Pepper C, Thomas A, Hoy T, Bentley P.
    Br J Haematol; 1999 Mar 01; 104(3):581-8. PubMed ID: 10086798
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 01; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 38. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C, Dreyling M, Hoster E, Pfreundschuh M, Trumper L, Reiser M, Wandt H, Lengfelder E, Unterhalt M, Hiddemann W, German Low-Grade Lymphoma Study Group.
    Cancer; 2006 Sep 01; 107(5):1014-22. PubMed ID: 16878325
    [Abstract] [Full Text] [Related]

  • 39. The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
    Coenen S, Pickering B, Potter KN, Johnson PW, Stevenson FK, Packham G.
    Haematologica; 2005 Sep 01; 90(9):1285-6. PubMed ID: 16154859
    [Abstract] [Full Text] [Related]

  • 40. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
    Thomas A, Pepper C, Hoy T, Bentley P.
    Leuk Res; 2000 Oct 01; 24(10):813-21. PubMed ID: 10996199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.